CB1 receptor antagonist precipitates withdrawal in mice exposed to δ9- tetrahydrocannabinol

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 3, 1998, Pages 1150-1156

  Cook, Stacie A ^b   Lowe, John A ^b   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG TOLERANCE; DRUG WITHDRAWAL; HAND MOVEMENT; HEAD MOVEMENT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREMOR; WITHDRAWAL SYNDROME;

ANALYSIS OF VARIANCE; ANIMALS; ANTIEMETICS; APPETITE STIMULANTS; BEHAVIOR, ANIMAL; HALLUCINOGENS; MALE; MICE; MICE, INBRED ICR; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SUBSTANCE WITHDRAWAL SYNDROME; TETRAHYDROCANNABINOL;

EID: 0031863301     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 9-THC without alteration of cannabinoid receptor binding or mRNA levels in the whole brain. Pharmacol Biochem Behav 46:575-579.
2. Aceto M, Scates S, Lowe J and Martin B (1995) Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Eur J Pharmacol 282:R1-R2.
3. 9-tetrahydrocannabinol: Studies on precipitated and abrupt withdrawal. J Pharmacol Exp Ther 278:1290-1295.
4. Beardsley PM, Balster RL and Harris LS (1986) Dependence on tetrahydrocannabinol in rhesus monkeys. J Pharmacol Exp Ther 239:311-319.
5. Bhargava HN (1976) Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice. Psychopharm 49:267-270.
6. Bhargava HN (1978) Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome. Pharmacol Biochem Behav 8:7-11.
7. Cohen S, Lessin P, Hahn PM and Tyrell ED (1976) A 94-day cannabis study, in Pharmacology of Marihuana (Braude MC and Szara S ed) pp 621-626, Raven Press, New York.
8. 9-tetrahdrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277:586-594.
9. Compton DR, Dewey WL and Martin BR (1990) Cannabis dependence and tolerance production, in Addiction Potential of Abused Drugs and Drug Classes (Erickson KC, Javors MA and Morgan WW eds) pp 129-147, The Hayworth Press, Inc., Binghamton, NY.
10. 9-THC, CP 55,940 and WIN 55,212. J Pharmacol Exp Ther 271:1383-1390.
11. Fan F, Tao Q, Abood M and Martin BR (1996) Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Res 706:13-20.
12. Fraser JD (1949) Withdrawal symptoms in cannabis-indica addicts. Lancet 1:747-748.
13. Georgotas A and Zeidenberg P (1979) Observations on the effects of four weeks of heavy marihuana smoking on group interaction and individual behavior. Compr Psych 20:427-432.
14. Greenberg I, Mendelson JH, Kuehnle JC, Mello N and Babor TF (1976) Psychiatric and behavioral observations of casual and heavy marijuana users in a controlled research setting. Ann NY Acad Sci 282:72-84.
15. Herkenham M, Groen BGS, Lynn AB, De Costa BR and Richfield EK (1991) Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Res 552:301-310.
16. Hine B, Friedman E, Torellio M and Gershon S (1975) Morphine-dependent rats: Blockade of precipitated abstinence by tetrahydrocannabinol. Science 187:443-445.
17. 9-tetrahydrocannabinol: Tolerance to the stimulus effects. Psychopharmacology 36:243-253.
18. Jones RT (1983) Cannabis tolerance and dependence, in Cannabis and Health Hazards (Fehr KO and Kalant H eds) pp 617-689, Addiction Research Foundation, Toronto, Canada.
19. Jones RT and Benowitz N (1976) The 30-day trip -Clinical studies of cannabis tolerance and dependence, in Pharmacology of Marihuana (Braude MC and Szara S eds) pp 627-642, Raven Press, New York.
20. Jones RT, Benowitz N and Bachman J (1976) Clinical studies of cannabis tolerance and dependence. Ann NY Acad Sci 282:221-239.
21. Jones RT, Benowitz NL and Herning RI (1981) Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21:143S-152S.
22. 9-tetrahydrocannabinol -tolerant rats. Psychopharmacology 55:243-249.
23. Kaymakcalan S (1973) Tolerance to and dependence on cannabis. Bull Narc 25:39-47.
24. Kaymakcalan S (1979) Physiological and psychological dependence on the in rhesus monkeys, in Marihuana: Biological Effects. Advances in the Biosciences (Nahas GG and Paton WDM eds) pp. 142-149, Pergamon Press, Oxford.
25. McMillan DE, Dewey WL and Harris LS (1971) Characteristics of tetrahydrocannabinol tolerance. Ann NY Acad Sci 191:83-99.
26. Mendelson J, Kuehnle J, Greenberg I and Mello N (1976) Operant acquisition of marihuana in man. JPET 198:42-53.
27. Pertwee R (1993) The evidence for the existence of cannabinoid receptors. Gen Pharmacol 24:811-824.
28. Pertwee R, Griffin G, Lainton J and Huffman J (1995) Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur J Pharmacol 284:241-247.
29. Pertwee R, Stevenson L and Griffin G (1993) Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. Br J Pharmacol 110:1483-1490.
30. Pertwee RG (1991) Tolerance to and dependence on psychotropic cannabinoids, in The Biological Bases of Drug Tolerance and Dependence (Pratt JA ed) pp 231-263, Academic Press, New York.
31. Pertwee RG, Stevenson LA, Elrick DB, Mechoulam R and Corbett AD (1992) Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br J Pharmacol 105:980-984.
32. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC and Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
33. 3H]-SR 141716A a selective brain (CB1) cannabinoid receptor antagonist in rodent brain. Life Sci 58:1239-1247.
34. 9-THC) on open-field behavior in rats. Pharmacol Biochem Behav 1:243-249.
35. 9-Tetrahydrocannabinol and kappa opioids in mice. J Pharmacol.
36. Soueif MI (1967) Hashish consumption in Egypt, with special reference to psychosocial aspects. Bull Narc 19:1-12.
37. Tallarida RJ and Murray RB (1987) Graded dose-response, in Manual of Pharmacologic Calculations, pp 26-31, Springer-Verlag, New York.
38. 9-tetrahydrocannabinol on behavior, body temperature, brain amines and withdrawal-like behaviour in the rat. J Pharm Pharmacol 34:240-245.
39. 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur J Pharmacol 280:R13-R15.
40. 9tetrahydrocannabinol. Psychopharmacol 68:261-267.